China Pharma Hldgs Inc.

13F holders, Q3 2024 (September 30)
4holders
2new positions
2sold out
$0.24avg. 13F price*

At the end of Q3 2024, 4 institutions reported holding China Pharma Hldgs Inc. in their 13F filings, unchanged from Q2 2024. 2 opened new positions and 2 sold out. The largest holders were XTX Topco Ltd ($5K), Two Sigma Securities, LLC ($5K) and Marex Group Ltd ($3K).

Company
China Pharma Hldgs Inc.
CUSIP
16941T302
Latest filing quarter
Q1 2025

History

Number of 13F holders

0246 Q1 2024: 3Q1 2024Q2 2024: 4Q2 2024Q3 2024: 4Q3 2024Q4 2024: 5Q4 2024Q1 2025: 6Q1 2025

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions2$8K
Exits2$7K

All 13F filers, Q2 2024 → Q3 2024: 32,446 shares bought and 38,375 shares sold, net −5,929 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

XTX Topco Ltd 0.00% Reduce -24.9% 21,587 $5K
Two Sigma Securities, LLC 0.00% New 19,047 $5K
Marex Group Ltd 0.00% New 13,399 $3K
First Community Trust NA 0.00% No change 30 $7

"% of holder's portfolio" is CHINA PHARMA HLDGS INC's weight in each manager's 13F, not the share of China Pharma Hldgs Inc. the manager owns.